Uterine corpus cancer
MONDO:0006003A malignant neoplasm involving the body of uterus.
Also known as: body of uterus cancer, cancer of body of uterus, cancer of the corpus uteri, corpus uteri cancer, malignant body of uterus neoplasm, malignant neoplasm of body of uterus, uterine (including endometrial) cancer, uterine corpus cancer
2917 clinical trials for this condition and its sub-types, 33 tagged with Uterine corpus cancer itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Uterine corpus cancer
-
Endometrial serous adenocarcinoma 36 trials
-
Uterine corpus sarcoma 12 trials · 19 incl. sub-types
3 sub-types
- Leiomyosarcoma of the corpus uteri 9 trials Sub-types →
- Uterine corpus endometrial stromal sarcoma 0 trials
- Uterine corpus rhabdomyosarcoma 0 trials
-
Uterine body mixed cancer 0 trials · 14 incl. sub-types
4 sub-types
- Carcinosarcoma of the corpus uteri 13 trials
- Uterine corpus adenosarcoma 1 trial
- Uterine corpus adenocarcinofibroma 0 trials
- Uterine corpus carcinofibroma 0 trials
-
1 sub-type
- Uterine corpus choriocarcinoma 0 trials
-
Uterine corpus endometrial carcinoma 0 trials
Most studied deeper sub-types
-
Could a cancer drug shrink endometrial tumors?
Disease control CompletedThis phase 2 trial tested the drug cabozantinib in 102 women with endometrial cancer that had returned or spread. The drug works by blocking enzymes that help tumors grow and by cutting off their blood supply. Researchers measured how many patients saw their tumors shrink or stop…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Cancer Survivors' sex drive gets a boost: bupropion shows promise
Symptom relief CompletedThis study tested whether bupropion, a medication that affects brain chemicals, can improve low sexual desire in women who have had breast or gynecologic cancer. About 230 women took either bupropion or a placebo pill for 9 weeks. The main goal was to see if their self-reported s…
Phase 2 • Sponsor: NRG Oncology • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Remote strength training aims to boost endometrial cancer survivorship in rural areas
Symptom relief CompletedThis study tests a 10-week, remotely supervised strength training program for endometrial cancer survivors living in rural or underserved areas. The goal is to see if the program is practical and helps improve physical function and quality of life. Participants exercise twice a w…
Sponsor: Mayo Clinic • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Smart devices track cancer recovery at home
Knowledge-focused CompletedThis study tested whether using at-home monitoring devices (like a wristband pedometer, scale, and blood pressure cuff) can help improve care for cancer patients after they leave the hospital following surgery. 22 patients with various cancers participated. The goal was to see if…
Sponsor: City of Hope Medical Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:02 UTC